Market Access Part Two: Navigating the complexities of global market acces... The journey to global market access for innovative therapies is fraught with challenges that vary significantly across the world.
Views & Analysis Effective decision making in early asset development and com... Addressing the data and evidence gap in the early stages of asset development.
News NHS trust rolls out digital health tool for kidney disease An NHS trust in England is starting a pilot study of a digital health platform that promises to improve the care of people with kidney disease.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face